The evidence for GLP-1 medications in treating NASH (the more severe form of fatty liver disease) is particularly impressive: Liraglutide achieved histological resolution of steatohepatitis in 39% of cases after 48 weeks, compared to just 9% in placebo groups 20 Patients taking liraglutide had 4.5 times higher likelihood of NASH resolution than those on placebo 20 Semaglutide demonstrated NASH resolution in 59% of participants versus 17% in placebo groups 21 We offer FibroScan technology to measure liver stiffness and fat content, helping us monitor your progress while on GLP-1 therapy
Where they differ is in their approach: Noom offers more GLP-1 options and leans heavily on psychology-based lessons and cognitive behavior strategies, while Weight Watchers centers its program around branded meds, a points system, and community support
I am feeling so much better
Also, it is a double functional cosmetic for whitening & anti wrinkle that complete to make bright skin tone
When GLP- 1 receptor agonists are used to treat T2DM, there is also a noticeable reduction in post-meal glycemic fluctuations due to their short-term, transient effect on slowing gastric emptying